Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 91, Issue 5, Pages 389-400Publisher
SPRINGER
DOI: 10.1007/s00280-023-04529-4
Keywords
Cardiotoxicity; Chemotherapy; Mitochondrial oxidative stress; Mitochondrial dysfunction; Mitochondria-targeted antioxidant; Combinatorial therapy
Categories
Ask authors/readers for more resources
This study investigated the cardioprotective potential of mito-TEMPO against 5-FU-induced cardiotoxicity. The results showed that mito-TEMPO could decrease the levels of cardiac injury markers, improve histopathology, and preserve mitochondrial function. It also reduced mitochondrial oxidative stress and apoptotic cell death.
PurposeThe mitochondria-targeted antioxidants (MTAs) are known to offer protection against mitochondrial oxidative stress. The recent evidences support their role in mitigating oxidative stress-induced diseases, including cancer. Therefore, this study investigated cardioprotective potential of mito-TEMPO against 5-FU-induced cardiotoxicity.MethodsMito-TEMPO was administered to male BALB/C mice (intraperitoneally, 0.1 mg/kg b.w. for 7 days) followed by intraperitoneal administration of 5- FU (12 mg/kg b.w. for 4 days). During this period, mito-TEMPO treatment was also continued. The cardioprotective potential of mito-TEMPO was assessed by evaluating cardiac injury markers, extent of non-viable myocardium and histopathological alterations. Mitochondrial functional status and mitochondrial oxidative stress were assessed in cardiac tissue. 8-OHdG expression and apoptotic cell death were assessed using immunohistochemical techniques.ResultsThe level of cardiac injury markers CK-MB and AST were significantly (P <= 0.05) decreased in mito-TEMPO pre-protected group which was further reflected in histopathology as decrease in the percentage of non-viable myocardial tissue, disorganization, and loss of myofibrils. Mito-TEMPO ameliorated mtROS, mtLPO and conserved mitochondrial membrane potential. Further, it had significantly (P <= 0.05) improved the activity of mitochondrial complexes and mitochondrial enzymes. A significant (P <= 0.05) increase in the level of mtGSH, activity of mitochondrial glutathione reductase, glutathione peroxidase, and mitochondrial superoxide dismutase was observed. A decreased expression of 8-OHdG and reduced apoptotic cell death were observed in mito-TEMPO pre-protected group.ConclusionMito-TEMPO effectively mitigated 5-FU-induced cardiotoxicity by modulating mitochondrial oxidative stress, hence may serve as a protective agent/adjuvant in 5-FU-based combinatorial chemotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available